6505NCM173720: FULVESTRANT INJECTION.
The FULVESTRANT INJECTION is a the manufacturer industrial component. Key specifications include part_name_assigned_by_controlling_agency: FULVESTRANT INJECTION 250 MG PER 5 ML (50 MG/ML), 2 PRE-FILLED SYRINGES. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-666-4009, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | FULVESTRANT INJECTION 250 MG PER 5 ML (50 MG/ML), 2 PRE-FILLED SYRINGES |
| NSN | 6505-01-666-4009 |
| SPECIAL FEATURES | FULVESTRANT INJECTION: 250 MG OF ACTIVE INGREDIENT PER 5 ML, (50 MG/ML), 2 PRE FILLED GLASS SYRINGES; FOR IM ADMINISTRATION; SINGLE PATIENT USE; BOTH SYRINGES MUST BE USED TO RECEIVE THE 500 MG DOSE; REQUIRES REFRIG BTWN 2-8 DEGREES C; DO NOT FREEZE; PROTECT FROM LIGHT; STORE IN THE ORIGINAL CARTON UNTIL TIME OF USE; HAZARDOUS CONTAINS ETHYL ALCOHOL AND BENZYL ALCOHOL; USED FOR THE TREATMENT OF HORMONE RECEPTOR POSITIVE METASTATIC BREAST CANCER IN POSTMENOPAUSAL WOMEN WITH DISEASE PROGRESSION FOLLOWING ANTI-ESTROGEN THERAPY |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | FULVESTRANT INJECTION 250 MG PER 5 ML (50 MG/ML), 2 PRE-FILLED SYRINGES |